A cluster randomized, single-centre, controlled, parallel,12-month prospective study and additional 12-month follow-up in Africa of malaria incidence in a community setting following systematic treatment of P. Falciparum asymptomatic carriers with artemether-lumefantrine (Coartem/Coartem Dispersible)

Trial Profile

A cluster randomized, single-centre, controlled, parallel,12-month prospective study and additional 12-month follow-up in Africa of malaria incidence in a community setting following systematic treatment of P. Falciparum asymptomatic carriers with artemether-lumefantrine (Coartem/Coartem Dispersible)

Not stated
Phase of Trial: Phase IV

Latest Information Update: 07 Apr 2016

At a glance

  • Drugs Artemether/lumefantrine (Primary)
  • Indications Malaria
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 07 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top